✦ LIBER ✦

ChemInform Abstract: The Unique Properties of Dipeptidyl-Peptidase IV (DPP IV / CD26) and the Therapeutic Potential of DPP IV Inhibitors

✍ Scribed by K. Augustyns; G. Bal; G. Thonus; A. Belyaev; X. M. Zhang; W. Bollaert; A. M. Lambeir; C. Durinx; F. Goossens; A. Haemers

Publisher: John Wiley and Sons
Year: 2010
Weight: 27 KB
Volume: 30
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.199929294

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Piperidinyl-2-phene

ChemInform Abstract: Piperidinyl-2-phenethylamino Inhibitors of DPP-IV for the Treatment of Type 2 Diabetes.

✍ John W. Benbow; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 13 KB 👁 1 views

ChemInform Abstract: The Asymmetric Synt

ChemInform Abstract: The Asymmetric Synthesis of Sitagliptin, a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Feng Liu; Wansheng Yu; Wenhua Ou; Xiaoke Wang; Libo Ruan; Yiming Li; Xijiang Pen 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

## Abstract Key step in the improved synthetic pathway to sitagliptin (VII), a new DPP‐IV inhibitor for the treatment of type 2 diabetes mellitus, is an asymmetric Michael addition to give intermediate (IV).

ChemInform Abstract: Discovery of Carmeg

ChemInform Abstract: Discovery of Carmegliptin (I): A Potent and Long-Acting Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Patrizio Mattei; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 16 KB 👁 2 views

Regulatory role of adenosine deaminase c

Regulatory role of adenosine deaminase complexing protein (dipeptidyl peptidase IV = CD26) on the malignancy marker adenosine deaminase: Effect of membrane cholesterol and phase-transition

✍ Abraham H. Parola; Valeria R. Caiolfa; Itzhak Ben-Shooshan; Rivka Cohen-Luria 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

While adenosine deaminase (ADA) is an established malignancy marker and its clinical involvement in severe combined immunodeficiency (SCID) is understood, the biological significance of its binding to adenosine deaminase complexing protein (CP = DPPIV = CD26) remains enigmatic. The role of lipid-pro